Literature DB >> 12175341

Expression of annexin-1 in multiple sclerosis plaques.

S Probst-Cousin1, D Kowolik, K Kuchelmeister, C Kayser, B Neundörfer, D Heuss.   

Abstract

This study describes the distribution and identity of annexin-1 positive cells in the central nervous system in patients with multiple sclerosis (MS). Glucocorticoid-inducible, anti-inflammatory properties have been ascribed to annexin-1, a member of a family of calcium-binding proteins that are referred to collectively as annexins. We have found annexin-1 to be spatially associated with active MS lesions and demonstrated a stage-dependent expression of annexin-1 in MS plaques. All of the most important pathogenetically involved cells of MS lesions showed a strong annexin-1 reactivity. Both correlation analysis and double staining procedures suggested annexin-1 expression in macrophages and perivascular lymphocytes, where a cytoplasmic reactivity was displayed, whereas in activated, gemistocytic astrocytes it was also concentrated close to the plasma membrane. Although the exact roles of annexin-1 in this setting are still to be determined, a possible contribution to anti-inflammatory processes might be suggested.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12175341     DOI: 10.1046/j.1365-2990.2002.00396.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  14 in total

1.  Annexin A1: a central player in the anti-inflammatory and neuroprotective role of microglia.

Authors:  Simon McArthur; Enrico Cristante; Mario Paterno; Helen Christian; Federico Roncaroli; Glenda E Gillies; Egle Solito
Journal:  J Immunol       Date:  2010-10-20       Impact factor: 5.422

2.  Proteomic strategies in multiple sclerosis and its animal models.

Authors:  Stella Elkabes; Hong Li
Journal:  Proteomics Clin Appl       Date:  2007-10-16       Impact factor: 3.494

3.  Gene expression profiling of human neural progenitor cells following the serum-induced astrocyte differentiation.

Authors:  Shinya Obayashi; Hiroko Tabunoki; Seung U Kim; Jun-ichi Satoh
Journal:  Cell Mol Neurobiol       Date:  2009-01-07       Impact factor: 5.046

4.  Identification of an essential endogenous regulator of blood-brain barrier integrity, and its pathological and therapeutic implications.

Authors:  Enrico Cristante; Simon McArthur; Claudio Mauro; Elisa Maggioli; Ignacio A Romero; Marzena Wylezinska-Arridge; Pierre O Couraud; Jordi Lopez-Tremoleda; Helen C Christian; Babette B Weksler; Andrea Malaspina; Egle Solito
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-31       Impact factor: 11.205

Review 5.  Annexin-A1: Therapeutic Potential in Microvascular Disease.

Authors:  Gareth S D Purvis; Egle Solito; Christoph Thiemermann
Journal:  Front Immunol       Date:  2019-04-30       Impact factor: 7.561

6.  Proteomic analysis of human cerebral endothelial cells activated by multiple sclerosis serum and IFNbeta-1b.

Authors:  J Steven Alexander; Alireza Minagar; Michael Harper; Sherry Robinson-Jackson; Merilyn Jennings; Stacy J Smith
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 2.866

Review 7.  The restorative role of annexin A1 at the blood-brain barrier.

Authors:  Simon McArthur; Rodrigo Azevedo Loiola; Elisa Maggioli; Mariella Errede; Daniela Virgintino; Egle Solito
Journal:  Fluids Barriers CNS       Date:  2016-09-21

8.  The Role and Effects of ANXA1 in Temporal Lobe Epilepsy: A Protection Mechanism?

Authors:  Bao-Zhen Bao Yao; Shi-Qian Yu; Hao Yuan; Hai-Ju Zhang; Ping Niu; Jing-Ping Ye
Journal:  Med Sci Monit Basic Res       Date:  2015-11-26

9.  Annexin A1 translocates to nucleus and promotes the expression of pro-inflammatory cytokines in a PKC-dependent manner after OGD/R.

Authors:  Baoming Zhao; Jing Wang; Lu Liu; Xing Li; Shuangxi Liu; Qian Xia; Jing Shi
Journal:  Sci Rep       Date:  2016-07-18       Impact factor: 4.379

10.  Augmenting Endogenous Levels of Retinal Annexin A1 Suppresses Uveitis in Mice.

Authors:  Peter J Gardner; Samia Yazid; Joana Ribeiro; Robin R Ali; Andrew D Dick
Journal:  Transl Vis Sci Technol       Date:  2017-10-05       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.